Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2014

Nov 4, 2014

29831_dirs_2014-11-03_6510fe10-6dac-4c38-84eb-5852e20b0d8a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2014-10-30

Reporting Person: READ IAN C (Director, Chairman & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-10-30 Common Stock M 54585.0000 $17.0300 Acquired 1465906.0000 Direct
2014-10-30 Common Stock F 15375.0000 $29.8400 Disposed 1450531.0000 Direct
2014-10-30 Common Stock F 24169.0000 $28.7500 Disposed 1426362.0000 Direct
2014-10-30 Common Stock S 67500.0000 $29.7600 Disposed 1358862.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-10-30 Stock Appreciation Rights $17.0300 M 54585.0000 Disposed 2014-10-30 Common Stock (54585.0000) Direct
2014-10-31 Phantom Stock Units SSP $ A 153.0000 Acquired Common Stock (153.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 9785.0000 Indirect
Common Stock 33809.0000 Indirect

Footnotes

F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

F5: In accordance with the provisions of his Grantor Retained Annuity Trust (GRAT), 27,800 shares were transferred from the GRAT to the reporting person's direct ownership on September 17, 2014.

F6: Each unit represents one phantom share of common stock.

F7: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.